68Ga-HBED-CC-PSMA

DRUG2 trials

Sponsors

UNC Lineberger Comprehensive Cancer Center

Conditions

Prostate Cancer

Phase 2

PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study

TerminatedNCT04176497

UNC Lineberger Comprehensive Cancer CenterProstate Cancer

Start: 2020-07-16End: 2024-10-25Updated: 2025-12-11

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

WithdrawnNCT04243941

UNC Lineberger Comprehensive Cancer CenterProstate Cancer

Start: 2022-11-29End: 2024-02-07Updated: 2024-03-21